Advertisement
Advertisement
U.S. Markets close in 11 mins
Advertisement
Advertisement
Advertisement
Advertisement

Allmed Medical Products Co., Ltd (002950.SZ)

Shenzhen - Shenzhen Delayed Price. Currency in CNY
12.60+0.03 (+0.24%)
At close: 03:04PM CST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in CNY

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 2/1/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.18
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 315.62
52 Week Low 39.88
50-Day Moving Average 312.78
200-Day Moving Average 312.46

Share Statistics

Avg Vol (3 month) 37.46M
Avg Vol (10 day) 32.32M
Shares Outstanding 5633.27M
Implied Shares Outstanding 6N/A
Float 8172.43M
% Held by Insiders 172.71%
% Held by Institutions 10.61%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.21
Forward Annual Dividend Yield 41.64%
Trailing Annual Dividend Rate 30.88
Trailing Annual Dividend Yield 37.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 427.54%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 09, 2022
Last Split Factor 21:1
Last Split Date 3Jun 05, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Jun 30, 2022

Profitability

Profit Margin 13.57%
Operating Margin (ttm)15.55%

Management Effectiveness

Return on Assets (ttm)6.60%
Return on Equity (ttm)17.38%

Income Statement

Revenue (ttm)3.56B
Revenue Per Share (ttm)5.62
Quarterly Revenue Growth (yoy)68.80%
Gross Profit (ttm)872.17M
EBITDA 712.44M
Net Income Avi to Common (ttm)483.54M
Diluted EPS (ttm)1.87
Quarterly Earnings Growth (yoy)9.00%

Balance Sheet

Total Cash (mrq)1.05B
Total Cash Per Share (mrq)1.66
Total Debt (mrq)1.69B
Total Debt/Equity (mrq)57.25
Current Ratio (mrq)1.29
Book Value Per Share (mrq)4.79

Cash Flow Statement

Operating Cash Flow (ttm)863.94M
Levered Free Cash Flow (ttm)507.74M
Advertisement
Advertisement